Gonal-f Rff Redi-ject Injection, Solution
Product Images NDC 44087-1117

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Gonal-f Rff Redi-ject (NDC 44087-1117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Gonal F 01)

Gonal-f RFF Redi-ject injection pen showing the product name and the available strengths: 300 IU/0.5 mL, 450 IU/0.75 mL, and 900 IU/1.5 mL. This subcutaneous solution for injection is labeled as prescription only, manufactured by EMD Serono, Inc.*

FDA Label Image

Figure (Gonal F 02)

Gonal-f RFF Redi-ject injection solution packaging label showing available strengths: 300 IU/0.5 mL, 450 IU/0.75 mL, and 900 IU/1.5 mL. This human prescription drug contains follitropin and is labeled by EMD Serono, Inc. The label displays the dosage strengths in a color-coded layout.*

FDA Label Image

Figure (Gonal F 03)

An illustration of a clock face showing a 30-minute time period highlighted. The graphic visually represents a 30-minute interval, suggesting timing or duration.*

FDA Label Image

Figure (Gonal F 04)

An illustration showing three items related to drug administration: a red sharps disposal container with a white lid, a small rectangular card or piece of paper, and a blue pen or similar writing instrument, arranged on a white background.*

FDA Label Image

Figure (Gonal F 05)

Illustration of the Gonal-f RFF Redi-ject prefilled injection pen for subcutaneous use. The diagram labels the pen cap, reservoir, plunger piston, threaded needle connector, expiration date, dose information display, and dose knob. Also shown are the outer needle cap, green inner needle shield, removable needle, and peel-off seal components.*

FDA Label Image

Figure (Gonal F 06)

An instructional illustration showing proper handwashing technique, depicting hands being rinsed under running water from a faucet. This type of image is commonly used to demonstrate hygiene steps prior to medication administration or medical procedures.*

FDA Label Image

Figure (Gonal F 07)

The image shows the Gonal-f RFF Redi-ject prefilled injection pen in its open packaging box. The pen is for subcutaneous injection and contains the active ingredient follitropin. The packaging is branded by EMD Serono, Inc. The box includes the injection pen along with necessary accessories.*

FDA Label Image

Figure (Gonal F 08)

The image shows an expiration date printed on a product, reading 'EXP April 30 2019'. This is a close-up of a part of the Gonal-f RFF Redi-ject injection pen or its packaging, associated with the follitropin subcutaneous injection by EMD Serono, Inc.*

FDA Label Image

Figure (Gonal F 09)

An instructional diagram showing the recommended injection area for a subcutaneous injection, specifically the lower abdominal region. The injection area is highlighted in blue to indicate the safe zone for administration.*

FDA Label Image

Figure (Gonal F 10)

An instructional illustration showing a hand holding a syringe with a needle being attached or inserted into a pen-like injector device. The image suggests preparation of a subcutaneous injection, relevant to injectable drug devices such as the Gonal-f RFF Redi-ject.*

FDA Label Image

Figure (Gonal F 11)

An instructional illustration showing a hand holding a Gonal-f RFF Redi-ject injection device, demonstrating how to remove or use the device on a person's abdomen for subcutaneous injection.*

FDA Label Image

Figure (Gonal F 12)

An instructional illustration showing a hand holding and removing a cap from a prefilled syringe, with a blue arrow indicating a twisting or turning motion. The image demonstrates part of the preparation process for using an injection device.*

FDA Label Image

Figure (Gonal F 13)

An instructional illustration showing a hand holding a protective cap being removed from a syringe needle. A blue arrow indicates the direction of cap removal, emphasizing preparation of the syringe for injection.*

FDA Label Image

Figure (Gonal F 14)

An instructional illustration showing the removal of a green protective cap from a vial with arrows indicating upward and downward motions, along with a hand holding the cap and a waste container, suggesting proper disposal of the cap after use.*

FDA Label Image

Figure (Gonal F 15)

An illustration showing a vial with a needle inserted into its rubber stopper, demonstrating proper technique for drawing medication from the vial, related to the subcutaneous injection of Gonal-f RFF Redi-ject (follitropin).*

FDA Label Image

Figure (Gonal F 16)

An instructional illustration showing hands holding a Gonal-f RFF Redi-ject injection pen. The image highlights twisting or turning the red cap, indicated by a blue arrow, presumably demonstrating preparation steps for subcutaneous injection of the Follitropin solution.*

FDA Label Image

Figure (Gonal F 17)

Gonal-f RFF Redi-ject injection pen displaying a partial view of the dosage window set to 150. This subcutaneous injection device is used for delivering follitropin, manufactured by EMD Serono, Inc.*

FDA Label Image

Figure (Gonal F 18)

Instructional illustration showing a hand holding a Gonal-f RFF Redi-ject injection device being inserted subcutaneously into the skin at a 90-degree angle. The image visually guides correct needle placement for the injection.*

FDA Label Image

Figure (Gonal F 19)

An instructional illustration showing a hand holding a Gonal-f RFF Redi-ject injection device with the red dose knob. The text instructs to hold down the dose knob and count slowly to 5, indicating a step in the injection process.*

FDA Label Image

Figure (Gonal F 20)

An instructional illustration shows a hand holding the Gonal-f RFF Redi-ject injection device, preparing it by pushing or twisting the plunger. The background includes a white surface indicating the setup or preparation area for subcutaneous injection.*

FDA Label Image

Figure (Gonal F 21)

An instructional diagram showing a close-up of a Gonal-f RFF Redi-ject injection pen's dosing window and an arrow indicating the direction to turn or adjust the dose. The image highlights the dose selection mechanism for the subcutaneous injection solution.*

FDA Label Image

Figure (Gonal F 22)

Illustrative images showing how to prepare and use the Gonal-f RFF Redi-ject injection device. The first image depicts a hand twisting a protective cap off a prefilled injection pen, while the second image shows the injection pen capped with a safety cover. These images guide proper handling and dosage preparation for subcutaneous injection of follitropin solution.*

FDA Label Image

Figure (Gonal F 23)

An instructional illustration showing a hand holding a pen injector labeled Gonal-f RFF Redi-ject, with an arrow pointing right indicating the direction to slide or remove a cover or sleeve from the injector.*

FDA Label Image

Figure (Gonal F 24)

Illustration showing a close-up of a hand adjusting the dosage setting on the Gonal-f RFF Redi-ject injection pen. The dose indicator window displays a numerical value, with a blue arrow indicating rotation to change the dose amount.*

FDA Label Image

Figure (Gonal F 25)

An instructional illustration showing a person pressing the top of a syringe with their finger, with an arrow indicating downward pressure. The syringe is marked with measurement lines and contains a clear liquid, likely demonstrating how to use or activate the Gonal-f RFF Redi-ject injection device.*

FDA Label Image

Figure (Gonal F 26)

An instructional illustration showing the Gonal-f RFF Redi-ject injection device with a close-up of the vial containing the solution, a hand holding the prefilled syringe, and a detailed view of the dose display on the syringe. The injection is a subcutaneous solution of follitropin, highlighting the device's features for administration.*

FDA Label Image

Figure (Gonal F 27)

Gonal-f RFF Redi-ject injection, solution packaging. The image shows a small red and white plastic container, likely the protective case or delivery device for the injection solution. No text or strength details are visible on the container itself. Labeler is EMD Serono, Inc.*

FDA Label Image

Figure (Gonal F 28)

A treatment diary chart for Gonal-f RFF Redi-ject injection, solution, showing columns for treatment day, date, time, pen IU strengths (300 IU, 450 IU, 900 IU), intended dose, confirmation of dose completion, instructions if dose is incomplete, and a notes section.*

FDA Label Image

Figure (Gonal F 29)

A treatment diary table illustrating instructions for recording injection details of Gonal-f RFF Redi-ject (Follitropin) pen doses. Columns include treatment day, date, time, pen IU strengths (300, 450, 900 IU), intended dose, confirmation if dose information display shows "0" after injection, second injection instructions if dose incomplete, and notes about injection status completion.*

FDA Label Image

Principal Display Panel (300 IU Kit Carton)

Label for Gonal-f RFF Redi-ject 300 IU/0.5 mL (follitropin alfa injection) solution for subcutaneous injection. The label includes instructions not to shake and notes the package contains one injection device and five 29-gauge needles. The labeler is EMD Serono, Inc.*

FDA Label Image

Principal Display Panel (450 IU Kit Carton)

Gonal-f RFF Redi-ject 450 IU/0.75 mL injection solution label for subcutaneous use. The label features the product name, active ingredient follitropin alfa, and instructions not to shake. It also notes seven 29-gauge needles included for injection. The label is from EMD Serono, Inc.*

FDA Label Image

Principal Display Panel (900 IU Kit Carton)

Label for Gonal-f RFF Redi-ject 900 IU / 1.5 mL subcutaneous injection solution containing follitropin alfa. The label instructs not to shake, indicates prescription use only, and notes the package includes 14 needles (29 gauge). The labeler is EMD Serono, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.